| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6df885157441d009872c020ab4a1d203 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2013-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fdffc1418440924464998530197dc0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1e4eae646ebd0b2500c9315ecc71a95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcec38c4f266ef45503cc19607227cb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac6ea2cfd78183fc7a415a489e87d23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c07cb213a0f8d1ff9b1929feb560d1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8c6f72f91c9d8c89e03b595592c5f96 |
| publicationDate |
2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2876908-A1 |
| titleOfInvention |
Casein kinase 1 inhibitors for the treatment of b-cell chronic lymphocytic leukemia |
| abstract |
The invention provides new medicaments for the treatment of the B-cell chronic lymphocytic leukemia, which are inhibitors of casein kinase 1. |
| priorityDate |
2012-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |